Search results
Moderna's combo Covid, flu vaccine meets goals in late-stage study - Boston Business Journal
The Business Journals· 5 days agoModerna Inc. is making steady headway on its plan to launch all four products from its respiratory...
Sarepta’s stock gains after Pfizer’s Duchenne trial failure - Boston Business Journal
The Business Journals· 2 days agoSarepta Therapeutics, a Cambridge drugmaker known for its Duchenne muscular dystrophy treatments,...
Public Employees Retirement Association of Colorado Has $1.55 Million Holdings in Exact Sciences Co....
ETF DAILY NEWS· 4 days agoPublic Employees Retirement Association of Colorado grew its stake in shares of Exact Sciences Co. (NASDAQ:EXAS – Free Report) by 58.2% during the fourth quarter, according to the company in ...
Just a Few Green Spaces in an Urban Landscape Can Boost Mental Health
Technology Networks· 6 days agoThe study, by Bangor University and Technion- Israel Institute of Technology, published in the...
Bird flu is rampant in animals. Humans ignore it at our own peril
ABC 7 Gulfshore News· 3 days agoMark Naniot remembers 2022 as the summer from hell. As the co-founder of Wild Instincts animal...
When Did Humans Domesticate Horses? Scientists Find Modern Lineage Has Origins 4,200 Years Ago
Smithsonian Magazine· 5 days agoThe domestication of horses is arguably among the most important achievements by early humans,...
Mass. biotech job postings drop 33% last year, report shows - Boston Business Journal
The Business Journals· 5 days agoMassachusetts’ life sciences job growth in 2023 slowed, but didn’t completely stall, as the industry...
Anavex Life Sciences Corp. Forecasted to Earn Q1 2025 Earnings of ($0.19) Per Share (NASDAQ:AVXL)
ETF DAILY NEWS· 3 days agoAnavex Life Sciences Corp. (NASDAQ:AVXL – Free Report) – Stock analysts at HC Wainwright issued their Q1 2025 EPS estimates for Anavex Life Sciences in a report released on Tuesday, June 11th ...
EHP Funds Inc. Sells 10,200 Shares of Gilead Sciences, Inc. (NASDAQ:GILD)
ETF DAILY NEWS· 5 days agoEHP Funds Inc. lowered its position in Gilead Sciences, Inc. (NASDAQ:GILD – Free Report) by 68.5% in the 4th quarter, according to the company in its most recent filing with the SEC. The fund ...
Official search is on for new CEO of Mass. Life Sciences Center - Boston Business Journal
The Business Journals· 3 days agoMassachusetts Life Sciences Center CEO Kenn Turner, who had been on leave for several months from the quasi-public organization before a brief return this spring, is leaving the agency for good ...